Trial intelligence / Profile preview

Oxytocin vs. Prostaglandin for Labor Induction in PROM

NCT02720978Phase 3Unknown

Sponsor
Tel Aviv Sourasky Medical Center
Start
May 2016
Primary completion
May 2019
Modality
Peptides, Small Molecules
01

Overview

A Phase 3 trial of oxytocin, dinoprostone in premature rupture of membranes (PROM), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.

02

Drugs

oxytocindinoprostone
03

Conditions

premature rupture of membranes (PROM)

Beyond the preview

Go deeper on NCT02720978.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02720978.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call